MariMed Inc. (OTC: MRMD) retail footprint has once again expanded, as the company officially unveiled an adult-use Thrive dispensary in Casey, Illinois
The reclassification of marijuana to a lower-risk Schedule III drug from Schedule I would allow cannabis companies to write off business expenses – a move that would boost cash flow and profits
Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.
MariMed Inc. MRMD retail footprint has once again expanded, as the company officially unveiled an adult-use Thrive dispensary in Casey, Illinois. This marks…